News for hackers. Stuff that matters.
Re:‘Pharmacy of the developing world’ under attack from the ... by creamyhorror on Tuesday August 25, 2015 @10:27AM (#10116695)
Look how Novartis and other drug companies are pricing their cancer drugs:

https://www.change.org/p/secretary-of-health-and-human-servi...

Prices have increased more than tenfold between 2000 (average price $5,000-$10,000 per year) and today (average price of new cancer drugs exceeds $120,000 per year).

http://www.nytimes.com/2015/01/15/opinion/why-drugs-cost-so-...

Novartis, the company that makes the leukemia drug Gleevec, keeps raising the drug’s price, even though the drug has already delivered billions in profit to the company. In 2001 Novartis charged $4,540, in 2014 dollars, for a month of treatment; now it charges $8,488. In its pricing, Novartis is just keeping up with other companies as they charge more and more for their drugs. They know we can’t say no.

http://www.nbcnews.com/health/cancer/utterly-broken-drug-mar...

Lauren Baumann is one of the lucky ones. Though she has cancer, chronic myeloid leukemia, it is manageable, as long as she takes a daily pill called Gleevec. Gleevec is considered a wonder drug, turning Lauren's leukemia from a death sentence to a disease she and thousands of others can live with. The problem is, even with health insurance and a full-time job, Lauren can't afford the monthly co-pay for Gleevec. It can be as high as $2,000 a month — twice the average mortgage payment in the U.S.

"I feel like you get punished," says Baumann. "I didn't ask to get cancer; I didn't ask to get sick. I was 26 and I was perfectly healthy."

This is essentially extortion due to price inelasticity of demand. $9,000-$12,500/month to survive, for the rest of your natural life! Patients+insurers have to pay whatever price the companies ask. For something as crucial as a life-saving drug, maybe the prices shouldn't be set only by market forces? Maybe generics should be allowed for import after patents expire the first time around?

(There are analyses of drug discovery costs around, and even after all those costs and reliance on basic research funded by taxpayer money, pharma companies make a very healthy profit. Much of the money goes into marketing, which we wouldn't need so much of in a system similar to the NHS which approves drugs for dispensing countrywide.)

Please sign the above Change.org petition (first link) and spread it! I normally don't make appeals, but this is one truly egregious case of unethical profiting.

An international panel of 115 doctors co-authored a paper decrying these ridiculous prices and offering 7 solutions, including allowing Medicare to negotiate drug prices once again (which they now aren't allowed to!):

http://www.forbes.com/sites/matthewherper/2015/07/23/155-ang...

Re:‘Pharmacy of the developing world’ under attack from the ... by ultramancool on Tuesday August 25, 2015 @10:31AM (#10116725)
> maybe the prices shouldn't be set only by market forces??

It's (arguably) not the market here that's the problem, but the patent. The patent means that generic manufacturers can't get in on the market and create a commodity out of it with a race to the bottom on price. The problem isn't the market, but the absolute lack of a market created by the exclusivity of a patent.

We need to find a way as a society that these companies can profit off the research and development of these drugs while still allowing generic manufacturers to do what they do best: create a real, competitive market to produce the drug in bulk.

Unfortunately I don't think there's any clear answers here.

Re:‘Pharmacy of the developing world’ under attack from the ... by brianwawok on Tuesday August 25, 2015 @10:34AM (#10116749)
Government funding the research + selling the drugs at cost would benefit mankind overall... but then politicians would decide how many $ to spend researching which drug per year, which has it's own downsides..
Re:‘Pharmacy of the developing world’ under attack from the ... by ekianjo on Tuesday August 25, 2015 @10:44AM (#10116845)
> Government funding the research + selling the drugs at cost would benefit mankind overall...

Wasnt that how NASA was supposed to work ? Oh wait, we know how it went...

Re:‘Pharmacy of the developing world’ under attack from the ... by RodericDay on Tuesday August 25, 2015 @11:11AM (#10117033)
We went to the moon?
Re:‘Pharmacy of the developing world’ under attack from the ... by ekianjo on Tuesday August 25, 2015 @11:17AM (#10117083)
I'm talking about what happened to NASA after that. Obviously look at the ridiculous budgets they have now.
Re:‘Pharmacy of the developing world’ under attack from the ... by JustSomeNobody on Tuesday August 25, 2015 @10:47AM (#10116862)
The problem, yet again, is quarterly earnings reports.

It takes sometimes billions to find the next new drug. In order to keep showing quarter after quarter of sustained growth that investors demand, they have to continue raising prices.

Fixing patents, wouldn't necessarily fix this problem.

Re:‘Pharmacy of the developing world’ under attack from the ... by ekianjo on Tuesday August 25, 2015 @10:48AM (#10116877)
> It takes sometimes billions to find the next new drug. In order to keep showing quarter after quarter of sustained growth that investors demand, they have to continue raising prices.

you don't raise prices on drugs that easily, Prices changes are heavily regulated as well.

Re:‘Pharmacy of the developing world’ under attack from the ... by judemelancon on Tuesday August 25, 2015 @05:05PM (#10119443)
I am aware of no such regulation in the USA. Are you?
Re:‘Pharmacy of the developing world’ under attack from the ... by ekianjo on Tuesday August 25, 2015 @10:47AM (#10116867)
> maybe the prices shouldn't be set only by market forces??

It's far from being a market-forces driven market. Pharma pricing is a heavily regulated market involving parties which are not the end consumer (Pricing Authorities, FDA, Pharma Companies, Insurance Companies, and sometimes Patient Advocate Groups).

That has about NOTHING to do with Free Market ideals.

Re:‘Pharmacy of the developing world’ under attack from the ... by creamyhorror on Tuesday August 25, 2015 @11:13AM (#10117041)
In the end, patients either get the drugs or they don't.

If pharmas set a certain pricing, the patients+insurers/Medicare feel the effect of that pricing, and respond accordingly. Patients have no choice but to take the price, and demand that insurers provide coverage for all cancer drugs. Insurers then spread the costs across their pool of insurees, resulting in skyrocketing premiums.

Did you know that Medicare isn't allowed to negotiate the prices of drugs, as part of regulatory concessions to pharma companies made in 2003?[1] What happens when Medicare (unlike other insurers) is forced to always pay what drug companies demand?

Further, in the case of Gleevec, the basic drug molecule was discovered by a university researcher, who went to Novartis to get it to invest in trials. So the costs aren't even fully borne by Novartis.

The system is broken and some possible solutions (proposed by researchers including those who discovered the drugs) should be evaluated. But strong lobbying from pharma is hard to get around.

[1] ...the 2003 Medicare Prescription Drug, Improvement, and Modernization Act contains legislation that forbids Medicare from negotiating drug prices. These policies have created an opportunity for drug companies, rendering them the sole decision makers on the price of cancer drugs. http://www.mayoclinicproceedings.org/article/S0025-6196%2815...

Re:‘Pharmacy of the developing world’ under attack from the ... by ekianjo on Tuesday August 25, 2015 @11:19AM (#10117097)
> Did you know that Medicare isn't allowed to negotiate the prices of drugs, as part of regulatory concessions to pharma companies?

Make this a vote by the people instead of relying on your leaders to make such changes. Referendums can be used for important measures.

Re:‘Pharmacy of the developing world’ under attack from the ... by TheCoelacanth on Tuesday August 25, 2015 @03:10PM (#10118814)
That would be a great idea if the US had a mechanism for referendums.
Re:‘Pharmacy of the developing world’ under attack from the ... by yummyfajitas on Tuesday August 25, 2015 @10:42AM (#10116822)
I'm a bit nervous about doing this. At the moment, I've got the possibility of paying $2k/month or dying. If we mess with a system that's clearly working, will I continue to have the choice of paying $2k/month?

For Gleevec, almost surely yes. But what about other undiscovered drugs?

Re:‘Pharmacy of the developing world’ under attack from the ... by ekianjo on Tuesday August 25, 2015 @10:33AM (#10116738)
> Patients have to pay whatever price the companies ask.

hello ? Prices are regulated by governments in most countries. You should start acting to make your government stop inflation on drug prices. Pharma companies can only abuse the system if you let them.

Re:‘Pharmacy of the developing world’ under attack from the ... by brianwawok on Tuesday August 25, 2015 @10:36AM (#10116770)
But where do most new drugs come from? (Not a rhetorical question, but serious).

If the US system of insane drug prices leads to 10x the drugs of a system of capped drug prices, I could see an argument to be made that insane drug prices are saving lives.

Re:‘Pharmacy of the developing world’ under attack from the ... by ekianjo on Tuesday August 25, 2015 @10:38AM (#10116796)
> But where do most new drugs come from? (Not a rhetorical question, but serious).

US market because that's the largest pharma market in the world, and it's the most friendly to businesses as well (since you can do direct to consumer advertising for pharma drugs, which is forbidden is about every other country). It's kind of natural that this is the market with the most innovation, but also where prices go the craziest, because of the way the insurance system is structured,

Re:‘Pharmacy of the developing world’ under attack from the ... by qwerty85344324i on Tuesday August 25, 2015 @10:49AM (#10116885)
Big pharma compoanies like Pfizer and Novartis generate lower net profit margins than Google and Apple. They're making less than 20 cents for every $1 in revenue. These are all public companies and you can look for their financial statements online.